glp-1 news september 2025 obesity drug today The GLP-1 trend: What the real-world data reveals GLP-1 Agonists Market Report 2025-2033,
Description
Trials excluded patients with prediabetes, and the abovementioned observational studies included patients with higher HbA1c levels at baseline, affecting the comparability
it's an innovation engine
doi: 10.1210/endo.142.3.8034
The exclusive expression of GCG in pancreatic -cells, enteroendocrine L cells, and some neurons in the brainstem underlines its pivotal role (57)
It feels bad to eat an entire meal the size I used to
Follow-up Duration : While trials extend to 72 weeks or longer, the chronic nature of obesity requires decades-long, unavailable safety and efficacy data
